Hong Kong stocks surged | Sangno Pharmaceutical-B (02257.HK) increased by over 18%, raising over 200 million Hong Kong dollars in share issuance, with participation from Huaxi Biotechnology and others.

According to the Wisdom Financial APP, Sino Biopharmaceutical Ltd. -B (02257.HK) has increased by over 18%, with a total increase of over 90% for the month. As of the time of writing, it has increased by 18.84% to HK$17.79, with a trading volume of HK$45.3042 million.